Enbrel vs Humira
Side-by-side comparison of Enbrel and Humira — mechanism, indications, safety, trials, sponsor, and pricing.
At a glance
| Enbrel | Humira |
|---|
| Generic name | Enbrel | Humira |
|---|
| Sponsor | LG Life Sciences | Sohag University |
|---|
| Molecular target | Tumor necrosis factor | Tumor necrosis factor |
|---|
| Modality | Small molecule | Small molecule |
|---|
| Phase | FDA-approved | FDA-approved |
|---|
| Therapeutic area | Oncology | Oncology |
|---|
Mechanism of action
Approved indications
Enbrel
- Ankylosing spondylitis
- Juvenile idiopathic arthritis
- Nonradiographic axial spondyloarthritis
- Plaque psoriasis
- Psoriasis with arthropathy
- Rheumatoid arthritis
Humira
- Ankylosing spondylitis
- Axial spondyloarthritis
- Behcet's disease
- Crohn's disease
- Hidradenitis suppurativa
- Juvenile idiopathic arthritis
- Non-infectious anterior uveitis
- Non-infectious intermediate, posterior and panuveitis
Common side effects
Enbrel
- Infections
- Injection site reactions
- Upper respiratory tract infection
- Sinusitis
- Influenza
Humira
- Injection site reactions
- Infections (upper respiratory, sinusitis)
- Headache
- Rash
Further reading